AMANDA DIMECH: Open Payments
NPI 1194437970 · SAN JOSE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$230 in 9 payments from 3 companies in 2025. Trend: 2023 $1,215 · 2024 $549 · 2025 $230
Food & beverage: $173Education: $57
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 4 | $92 |
| GENZYME CORPORATION | 4 | $81 |
| SANOFI-AVENTIS U.S. LLC | 1 | $57 |
Products named: DUPIXENT, NUCALA, TRELEGY ELLIPTA.
Industry payments across CA — which companies pay providers there.
